Avalo Therapeutics, Inc. short interest in 2024
In 2024, Avalo Therapeutics, Inc.'s disclosed short interest ran from 7.59% of shares outstanding on 28 Mar 2024 to 0.05% on 29 Nov 2024, a change of -7.54 percentage points. The year's high was 14.83% on 15 Apr 2024 and its low 0.05% on 29 Nov 2024, averaging 6.28% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.04 days on 31 Jul 2024. Full history: Avalo Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 7.59% (28 Mar 2024)
- End of year
- 0.05% (29 Nov 2024)
- Change
- -7.54 pp
- High
- 14.83% (15 Apr 2024)
- Low
- 0.05% (29 Nov 2024)
- Average
- 6.28%
- Highest days to cover
- 8.04 (31 Jul 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 28 Mar 2024 | 7.59% | 1.00 | |
| 15 Apr 2024 | 14.83% | 1.00 | 10-K filed, results (8-K) |
| 30 Apr 2024 | 10.09% | 1.07 | |
| 15 May 2024 | 8.04% | 1.35 | 10-Q filed, results (8-K) |
| 31 May 2024 | 7.91% | 3.02 | |
| 14 Jun 2024 | 7.29% | 5.48 | |
| 28 Jun 2024 | 7.24% | 3.71 | |
| 15 Jul 2024 | 6.26% | 5.21 | |
| 31 Jul 2024 | 5.67% | 8.04 | |
| 15 Aug 2024 | 5.45% | 6.48 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 4.17% | 1.00 | |
| 13 Sep 2024 | 5.75% | 4.98 | |
| 30 Sep 2024 | 5.24% | 4.06 | |
| 15 Oct 2024 | 4.76% | 3.09 | |
| 15 Nov 2024 | 0.09% | 1.00 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 0.05% | 1.00 |
See also: Avalo Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.